Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Scott

Showing results (221-230 of 224) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 224 results.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discoveryDaniel A Erlanson, Joseph W Arndt, Mark T Cancilla, et al.
Bioorganic & Medicinal Chemistry|July 27, 2021
Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitorsBrian T Hopkins, Eris Bame, Noah Bell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Uncovering a membrane-distal conformation of KRAS available to recruit RAF to the plasma membraneQue N Van, Cesar A López, Marco Tonelli, et al.
European Journal of Immunology|October 22, 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Pageof 23

Showing results (221-230 of 224) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 224 results.
Bioorganic & Medicinal Chemistry Letters|April 5, 2011
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discoveryDaniel A Erlanson, Joseph W Arndt, Mark T Cancilla, et al.
Bioorganic & Medicinal Chemistry|July 27, 2021
Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitorsBrian T Hopkins, Eris Bame, Noah Bell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Uncovering a membrane-distal conformation of KRAS available to recruit RAF to the plasma membraneQue N Van, Cesar A López, Marco Tonelli, et al.
European Journal of Immunology|October 22, 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Pageof 23